Not an SEC registrant

The Emmes Company, LLC

Customers

1 federal agency, 3 prime contractors

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$71.6M

FY2026 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 1

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $71.6M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services National Institutes of Health	$71.6M	FY 2026	52	$97.6M → $100.1M → $72.7M → $71.6M	75N93021C00012
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH IN INFECTIOUS DISEASES (SDCC) Award 75N93021C00012 on USAspending.gov ↗ Largest of 52 awards in FY2026: $26.2M obligated

Federal subcontracts received 3

Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.

Company	Subawards	Fiscal year	Count	Largest subaward
Digital Infuzion, LLC	$6.6M	FY 2025	3	75N93019C00078
EXERCISE AND FUND OY6. Prime award 75N93019C00078 on USAspending.gov ↗ Subaward F-NIAID-SDMCC-2732019-01 MOD 15: $3.4M · Department of Health and Human Services (HHS)
LDOS Leidos Holdings, Inc.	$2.0M	FY 2025	1	75N91024F00032
IN SUPPORT OF THE NIAID DMID H5N1 VACCINE CLINICAL TRIAL, LEIDOS BIOMED IS TASKED WITH THE MANAGEMENT OVERSIGHT AND CONDUCT OF THE H5N1 VACCINE CLINICAL TRIAL AND SEEKS TO CONTRACT WITH AN ORGANIZATION WITH THE CAPABILITIES TO PROVIDE DATA MANAGEMENT AND STATISTICAL ANALYSIS SUPPORT TO THE H5N1 VACCINE TRIAL AS OUTLINED IN THIS STATEMENT OF WORK. THE DATA MANAGEMENT AND STATISTICAL ANALYSIS ORGANIZATION SHOULD HAVE EXPERIENCE WITH INVESTIGATION NEW DRUG (IND) TRIALS, HAVE ALL THE NECESSARY REGULATORY REPORTING EXPERIENCE (PREFERABLY INFECTIOUS DISEASE), AND USE A VALIDATED 21 CODE OF FEDERAL REGULATIONS (CFR) PART 11 COMPLIANT SYSTEMS. Prime award 75N91024F00032 on USAspending.gov ↗ Subaward 23X079F3: $2.0M · Department of Health and Human Services (HHS)
International Aids Vaccine Initiative INC.	$1.8M	FY 2025	2	75A50121C00077
C104 BDM STATEMENT OF WORK (MARBURG) Prime award 75A50121C00077 on USAspending.gov ↗ Subaward A12548: $888.3K · Department of Health and Human Services (HHS)

Alerts are coming

Get an email when The Emmes Company, LLC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.